Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Lilly's Alzheimer's Gamble Aims at $10 Billion Patent Loss
Lilly's Alzheimer's Gamble Aims at $10 Billion Patent Loss
Lilly's Alzheimer's Gamble Aims at $10 Billion Patent Loss
Submitted by
admin
on July 13, 2010 - 8:39am
Source:
Bloomberg
News Tags:
Eli Lilly
Alzheimer's disease
semagacestat
solanezumab
Headline:
Lilly's Alzheimer's Gamble Aims at $10 Billion Patent Loss
Do Not Allow Advertisers to Use My Personal information
